So proud of @msu-medicine.bsky.social faculty Jenny Klomp! @MSUMD #AACRras26 #SpartansWill
Attending the AACR Special Conference on RAS Oncogenesis and Therapeutics? Join Lisa Situ, PhD, Assistant Editor of Cancer Discovery, at the Networking Roundtables tomorrow morning from 7:00 AM – 8:00 AM to learn about publishing your research. #AACRras26
Dieter Saur, Zachary Hauseman, James Duncan, and Jennifer Klomp discussed "Effector Signaling" in a plenary session at the AACR Special Conference on RAS Oncogenesis and Therapeutics.
#AACRras26 @saurlab.bsky.social
The first full day of the AACR Special Conference on RAS Oncogenesis and Therapeutics begins soon, featuring plenary sessions on RAS biochemistry, structure, and mutations as well as early detection advances. #AACRras26
Sandra Misale discussed "Response and Resistance to RAS Blockade in Solid Tumors and Beyond" in a Rising Star Lecture at the AACR Special Conference on RAS Oncogenesis and Therapeutics. #AACRras26 @sandramisale.bsky.social
Drugging RAS: What a Long, Strange Trip It’s Been – Channing Der addressed this topic in a keynote address to open the AACR Special Conference on RAS Oncogenesis and Therapeutics.
#AACRras26
The AACR Special Conference on RAS Oncogenesis and Therapeutics opens today in Los Angeles with a keynote address by Channing Der. #AACRras26
Attending #AACRras26? Lisa Situ, PhD, Assistant Editor of Cancer Discovery, would love to hear about your research! Connect with her to discuss publishing opportunities in the AACR Journals.
Poster presentation at AACR Ras conference, entitled Combination benefit of FAK inhibitor narmafotinib and KRAS inhibitors
I'll be attending next month's AACR Special Conference on Ras Oncogenesis and Therapeutics in Los Angeles to present a poster describing Amplia's preclinical studies of various kRAS inhibitors with our best-in-class FAK inhibitor narmafotinib.
#AACRras26 #FAK #pancreaticcancer
Register by January 19 to get the lowest rates for the AACR Special Conference on RAS Oncogenesis and Therapeutics (March 5-8, 2026; Los Angeles), chaired by Andrew J. Aguirre, Channing J. Der, David S. Hong, and Kevan M. Shokat. Learn more:
buff.ly/KSYsLWC
#AACRras26
Register by January 19 to get the lowest rates for the AACR Special Conference on RAS Oncogenesis and Therapeutics (March 5-8, 2026; Los Angeles), chaired by Andrew J. Aguirre, Channing J. Der, David S. Hong, and Kevan M. Shokat. Learn more:
buff.ly/KSYsLWC
#AACRras26
Register by January 19 to get the lowest rates for the AACR Special Conference on RAS Oncogenesis and Therapeutics (March 5-8, 2026; Los Angeles), chaired by Andrew J. Aguirre, Channing J. Der, David S. Hong, and Kevan M. Shokat. Learn more:
buff.ly/KSYsLWC
#AACRras26
Register by January 19 to get the lowest rates for the AACR Special Conference on RAS Oncogenesis and Therapeutics (March 5-8, 2026; Los Angeles), chaired by Andrew J. Aguirre, Channing J. Der, David S. Hong, and Kevan M. Shokat. Learn more:
buff.ly/KSYsLWC
#AACRras26
Submit an abstract by December 8 for the AACR Special Conference on RAS Oncogenesis and Therapeutics (March 5-8, 2026; Los Angeles), chaired by Andrew J. Aguirre, Channing J. Der, David S. Hong, and Kevan M. Shokat. Learn more:
buff.ly/KSYsLWC
#AACRras26
Submit an abstract by December 8 for the AACR Special Conference on RAS Oncogenesis and Therapeutics (March 5-8, 2026; Los Angeles), chaired by Andrew J. Aguirre, Channing J. Der, David S. Hong, and Kevan M. Shokat. Learn more:
buff.ly/KSYsLWC
#AACRras26
Response and Resistance to RAS Blockade in Solid Tumors and Beyond:
Sandra Misale will address this topic in a Rising Star Lecture at the AACR Special Conference on RAS Oncogenesis and Therapeutics (March 5-8, 2026; Los Angeles). Learn more:
buff.ly/3CZyAPA
#AACRras26 @sandramisale.bsky.social
Submit an abstract by December 8 for the AACR Special Conference on RAS Oncogenesis and Therapeutics (March 5-8, 2026; Los Angeles), chaired by Andrew J. Aguirre, Channing J. Der, David S. Hong, and Kevan M. Shokat. Learn more:
buff.ly/KSYsLWC
#AACRras26
Submit an abstract by December 8 for the AACR Special Conference on RAS Oncogenesis and Therapeutics (March 5-8, 2026; Los Angeles), chaired by Andrew J. Aguirre, Channing J. Der, David S. Hong, and Kevan M. Shokat. Learn more:
buff.ly/KSYsLWC
#AACRras26